Rounds v. GlaxoSmithKline, LLC et al
Consolidated
Lead case: 9:20-md-02924
Lead case: 9:20-md-02924
Florida Southern District Court | |
Judge: | Robin L Rosenberg |
Referred: | Bruce E Reinhart |
Case #: | 9:24-cv-80266 |
Nature of Suit | 365 Torts - Personal Injury - Product Liability |
Cause | 28:1332 Diversity-Notice of Removal |
Case Filed: | Mar 08, 2024 |
Terminated: | Mar 08, 2024 |
Case in other court: | Delaware, 1:24-cv-00217 |
Last checked: Thursday Sep 05, 2024 4:24 AM EDT |
Defendant
Boehringer Ingelheim Pharmaceuticals, Inc.
|
|
Defendant
Boehringer Ingelheim U.S.A. Corporation
|
|
Defendant
GlaxoSmithkline LLC
|
Represented By
|
Defendant
Patheon Manufacturing Services LLC
|
Represented By
|
Defendant
Pfizer, Inc.
|
|
Defendant
Sanofi U.S. Services Inc.
|
Represented By
|
Defendant
Sanofi-Aventis U.S. LLC
|
Represented By
|
Plaintiff
David Rounds
|
Represented By
|
Docket last updated: 11 hours ago |
Thursday, August 15, 2024 | ||
14 | 14
order
- Order (PAPERLESS or pdf attached)
Fri 08/16 2:27 PM
ORDER denying 7311 MOTION to Vacate or Decline to Enforce 5348 Pretrial Order No. 72 and Remand, filed in the main MDL action 20-md-2924. Signed by Judge Robin L. Rosenberg on 8/15/2024. See attached document for full details. (jas) |
|
Friday, June 21, 2024 | ||
13 | 13
order
- Order (PAPERLESS or pdf attached)
Fri 06/21 5:23 PM
ORDER denying Motion to Remand re 7264-1 Plaintiff's Motion to Remand in MDL case 20-md-20924. Signed by Judge Robin L. Rosenberg on 6/21/2024. See attached document for full details. (jas) |
|
Friday, March 08, 2024 | ||
12 | 12
4
pgs
order
Order Staying Case
Fri 03/08 1:00 PM
PRETRIAL ORDER # 80 Procedures for the Filing of All Future Claims in this MDL. Case is Administratively Closed and Stayed. Signed by Judge Robin L. Rosenberg on 3/8/2024. See attached document for full details. (jas) |
|
11 | 11
transfer
MDL Tag-Along/Transfer In Case Receipt
Fri 03/08 12:58 PM
MDL Transfer In Case Receipt from District of Delaware. Case Number 24-cv-00217-RGA with documents 1-8. Assigned FLSD Case Number 24-cv-80266-RLR. Re: FLSD MDL Case Number 20-MD-2924-RLR. (jas) |
|
10 | 10
order
Clerk's Notice of Judge Assignment and Optional Consent
Fri 03/08 12:57 PM
Clerks Notice of Judge Assignment to Judge Robin L. Rosenberg and Magistrate Judge Bruce E. Reinhart. (jas) |
|
9 | 9
transfer
Case Transferred In - District Transfer - CV - NO FEE
Fri 03/08 11:29 AM
Case transferred in from Delaware; Case Number 1:24-cv-00217. Electronic file including transfer order and docket sheet received. .(jas) |
|
Thursday, March 07, 2024 | ||
8 | 8 CONDITIONAL TRANSFER ORDER (CTO-123). Signed by Tiffaney D. Pete, Clerk of the Panel on 3/6/2024. (nms) | |
Case transferred to the United States District Court for the Southern District of Florida. (nms) | ||
Wednesday, March 06, 2024 | ||
7 | 7 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent DPI Newco LLC, Other Affiliate Thermo Fisher Scientific Inc. for Patheon Manufacturing Services LLC filed by Patheon Manufacturing Services LLC. (O'Kelly, Sean) | |
6 | 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sanofi SA for Sanofi U.S. Services, Inc., Sanofi-Aventis U.S. LLC filed by Sanofi U.S. Services, Inc., Sanofi-Aventis U.S. LLC. (Rappaport, Nancy) | |
Tuesday, February 27, 2024 | ||
SECOND DEFICIENCY NOTICE issued by the Court to Defendants Sanofi-Aventis U.S. LLC, Sanofi U.S. Services, Inc., and Patheon Manufacturing Services LLC: Pursuant to Fed. R. Civ. P. 7.1 (b)(1), A party must: (1) file the disclosure statement with its first appearance, pleading, petition, motion, response, or other request addressed to the court. Counsel is requested to supplement the docket with an appropriate Rule 7.1 Disclosure Statement. (nms) | ||
Wednesday, February 21, 2024 | ||
5 | 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Pfizer, Inc.. (Brown, Daniel) | |
4 | 4 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent GlaxoSmithKline plc. for GlaxoSmithKline, LLC filed by GlaxoSmithKline, LLC. (Brannigan, Patrick) | |
Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) | ||
DEFICIENCY NOTICE issued by the Court to Defendants Pfizer, Inc., Sanofi-Aventis U.S. LLC, Sanofi U.S. Services, Inc., GlaxoSmithKline, LLC, and Patheon Manufacturing Services LLC: Pursuant to Fed. R. Civ. P. 7.1 (b)(1), A party must: (1) file the disclosure statement with its first appearance, pleading, petition, motion, response, or other request addressed to the court. Counsel is requested to supplement the docket with an appropriate Rule 7.1 Disclosure Statement. (nms) | ||
Friday, February 16, 2024 | ||
3 | 3 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Boehringer Ingelheim USA Corporation for Boehringer Ingelheim Pharmaceuticals, Inc. filed by Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation. (jfm) | |
2 | 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) | |
1 | 1 NOTICE OF REMOVAL and copies of documents from DE Superior Court, Case Number N24C-01-194 ZAN (Filing fee $405, receipt number ADEDC-4341419)- filed by Boehringer Ingelheim Pharmaceuticals, Inc., Sanofi U.S. Services, Inc., Boehringer Ingelheim USA Corporation, Sanofi-Aventis U.S. LLC, GlaxoSmithKline, LLC, Pfizer, Inc., Patheon Manufacturing Services LLC.(jfm) | |
Att: 1 Exhibit A, | ||
Att: 2 Exhibit B, | ||
Att: 3 Exhibit C, | ||
Att: 4 Exhibit D, | ||
Att: 5 Certificate of Service, | ||
Att: 6 Civil Cover Sheet |